Group I: 29 patients (25 completed the study) that received the study agent (400mg of oral pentoxifylline daily for 6 months.), besides the appropriate weight-based dose of ESA (60-150I.U/kg/wk).

Group II: 28 patients (25 completed the study) who did not receive pentoxifylline but they received the appropriate dose of ESA. They were used as a control group and compared to group1 concerning the primary and the secondary outcomes.

Anemia of Chronic Kidney Disease

a known drug of xanthine derivatives used in intermittent claudication

Pentoxifylline

Tanta university hospital

Does Oral Pentoxifylline Administration Improve Hemoglobin in Hemodialysis Patients?

Effect of Pentoxifylline Administration on Hemoglobin Level of Hemodialysis Patients

the difference in haemoglobin concentration between the pentoxifylline and control group at the end of the 6 months study period.

Difference in CRP and albumin levels between the two groups

Sarah Abdel Mageed

Assistant lecturer of internal medicine

Tanta University

Neonatal Hyperbilirubinemia

Shoklo Malaria Research Unit

Study on Newborn Babies With a Yellow Skin Color (Neonatal Jaundice Study)

A Prospective Cohort Study on the Etiology of Neonatal Hyperbilirubinemia in a Migrant and Refugee Population on the Thai-Myanmar Border

Establish the causes contributing to the development of neonatal hyperbilirubinemia in this population, including a detailed description of the clinical course of neonates with neonatal hyperbilirubinemia.

hemoglobinopathies/albumin

Does Oral Pentoxifylline Administration Improve Hemoglobin in Hemodialysis Patients?

Study on Newborn Babies With a Yellow Skin Color (Neonatal Jaundice Study)

Najkompletnejšia databáza liečivých bylín podporovaná vedou